Panitumumab - Vectibix; ABX-EGF; epidermal growth factor receptor monoclonal antibody, human, recombinant; E7.6.3; rHuMAb-EGFr; transgenic XenoMouse-derived human EGF receptor Mab -- Product Record

EGF receptor Mab, human, rDNA/Amgen

    Nomenclature:
      EGF receptor Mab, human, rDNA/Amgen [BIO]
      Vectibix [TR]
      panitumumab [USAN INN]
      immunoglobulin, anti-(human epidermal growth factor receptor) (human monoclonal ABX-EGF heavy chain), disulfide with human monoclonal ABX-EGF light chain, dimer [CAS]
      339177-26-3 [CAS RN]
      ABX-EGF [SY]
      E7.6.3 [SY]
      epidermal growth factor receptor monoclonal antibody, human [SY]
      HuMAb-EGFr [SY]
      NDC 55513-954-01; NDC 55513-955-01; NDC 55513-956-01 [NDC]

    molecular weight (kDa) = 147

    FDA Class:  BLA Biologic

    Year of approval (FDA) = 2006